The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 9, Issue 3, Pages 144-155
Publisher
Springer Nature
Online
2012-02-14
DOI
10.1038/nrclinonc.2012.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels
- (2017) M. Cobo et al. JOURNAL OF CLINICAL ONCOLOGY
- ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis
- (2011) Gerold Bepler et al. AMERICAN JOURNAL OF PATHOLOGY
- Synthetic lethality: exploiting the addiction of cancer to DNA repair
- (2011) M. Shaheen et al. BLOOD
- DNA Repair: From Genome Maintenance to Biomarker and Therapeutic Target
- (2011) S. Jalal et al. CLINICAL CANCER RESEARCH
- Regulation of endonuclease activity in human nucleotide excision repair
- (2011) Adebanke F. Fagbemi et al. DNA REPAIR
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy
- (2011) Li-E Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer
- (2011) Zengliu Su et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer
- (2011) Ian Paul et al. JOURNAL OF PATHOLOGY
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- New strategies for targeting the therapy of NSCLC: the role of ERCC1 and TS
- (2010) P Ceppi et al. Advances in Medical Sciences
- ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
- (2010) B. Besse et al. ANNALS OF ONCOLOGY
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1
- (2010) Sarah A. Martin et al. CANCER CELL
- BRCA Gene Structure and Function in Tumor Suppression
- (2010) Conleth G. Murphy et al. CANCER JOURNAL
- Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
- (2010) C. Powell et al. CANCER TREATMENT REVIEWS
- MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer
- (2010) et al. CLINICAL CANCER RESEARCH
- A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
- (2010) M. Graeser et al. CLINICAL CANCER RESEARCH
- Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer
- (2010) Sacha I Rothschild et al. CURRENT OPINION IN ONCOLOGY
- Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non–Small-Cell Lung Cancer
- (2010) Kouya Shiraishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis
- (2010) Sufeng Chen et al. LUNG CANCER
- Synthetic lethal approaches to breast cancer therapy
- (2010) Farah L. Rehman et al. Nature Reviews Clinical Oncology
- Chromosomal and genomic changes in lung cancer
- (2010) Marileila Varella-Garcia Cell Adhesion & Migration
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
- (2009) Roberta Bartolucci et al. Clinical Lung Cancer
- A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
- (2009) Britta Stordal et al. CURRENT CANCER DRUG TARGETS
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair geneMSH2
- (2009) Sarah A. Martin et al. EMBO Molecular Medicine
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
- (2009) Guang Jin et al. LUNG CANCER
- CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
- (2009) Clark C Chen et al. Molecular Cancer
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
- (2009) Rafael Rosell et al. PLoS One
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
- (2008) Lifeng Wang et al. BMC CANCER
- Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
- (2008) J Souglakos et al. BRITISH JOURNAL OF CANCER
- Role of LKB1 in lung cancer development
- (2008) L Makowski et al. BRITISH JOURNAL OF CANCER
- DNA Repair Capacity and Lung Cancer Risk in Never Smokers
- (2008) O. Y. Gorlova et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prognostic significance of DNA repair proteins MLH1, MSH2 and MGMT expression in non-small-cell lung cancer and precursor lesions
- (2008) W A Cooper et al. HISTOPATHOLOGY
- DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors
- (2008) Irene Orlow et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance
- (2008) Hidenori Kouso et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer
- (2008) Gerold Bepler et al. Journal of Thoracic Oncology
- Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients
- (2008) Ioannis Boukovinas et al. PLoS One
- A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia
- (2008) Stanley K. Liu et al. RADIOTHERAPY AND ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now